B
EHC icon

Bailard’s Encompass Health EHC Stock Holding History

Bailard’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,942
Closed -$738K – 749
2024
Q1 		$738K Buy
+8,942
New +$655K 0.02% 359
2022
Q3 		– Sell
-5,908
Closed -$263K – 693
2022
Q2 		$263K Sell
5,908
-251
-4% -$12.9K 0.01% 526
2022
Q1 		$348K Buy
6,159
+1,634
+36% +$85.3K 0.01% 488
2021
Q4 		$235K Buy
+4,525
New +$233K 0.01% 629
2020
Q4 		– Sell
-8,422
Closed -$435K – 642
2020
Q3 		$435K Buy
+8,422
New +$432K 0.02% 310
2019
Q4 		– Sell
-7,291
Closed -$367K – 557
2019
Q3 		$367K Buy
+7,291
New +$366K 0.02% 358

Other funds holding EHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bailard's EHC Position: Q2 2024 in Review

Bailard sold out of Encompass Health (EHC) in Q2 2024, closing a stake of 8,942 shares — an estimated $738K sold.

Bailard first reported a position in EHC in Q3 2019 and held it in 6 quarters. The position peaked at $738K in Q1 2024. 477 funds tracked by Wall St. Rank hold EHC as of Q2 2024.

  • Bailard reported no remaining Encompass Health position as of Q2 2024 after selling out during the quarter.
  • Bailard sold 8,942 Encompass Health shares in Q2 2024, an estimated $738K.
  • Bailard first reported a position in Encompass Health in Q3 2019 and held it in 6 quarters.
  • Bailard's Encompass Health position peaked at $738K in Q1 2024.
  • 477 funds tracked by Wall St. Rank held Encompass Health as of Q2 2024.

Based on Bailard's 13F filing for Q2 2024, filed 25 Jul 2024.